Modern pharmacological research also showed that Xiao'aiping tablet could reduce the content of transforming growth factor-α (TGF-α) and vascular endothelial growth factor (VEGF) in patients with gastric cancer, to inhibit the invasion, metastasis, and angiogenesis of gastric cancer cells [50]. Here, TGFA is linked to gastric cancer.